Lifeway Foods (LWAY) Q3 2026 earnings review
Lifeway kefir sales hit a record, but profit nearly vanishes
Lifeway Foods, the main US maker of drinkable kefir and farmer cheese, set another sales record while higher milk and packaging bills wiped out most of its profit. Net sales rose 19% from a year ago to $68 million on strong kefir volumes, but gross margin fell to 18% and reduced profit per share to two cents. Chief executive Julie Smolyansky kept her 2027 recovery plan unchanged, even though she now expects input cost pressure to last through the fourth quarter instead of easing.
| Net sales | $67.8M +18.6% from a year ago |
|---|---|
| Gross profit margin | 18.0% 28.7% a year ago; 19.5% last quarter |
| Profit per share | $0.02 $0.23 a year ago |
| 2027 margin outlook | Unchanged expansion planned as price hikes roll in |
⚖️ Verdict: 🔴 Bearish
The story got worse because gross margin slipped further instead of stabilizing, and the cost relief previously expected in the fourth quarter was pushed out. For a second straight quarter, the release also left out the company's 2027 profit target. On the positive side, Lifeway began rolling out price increases that will finish taking effect in the first quarter of 2027, and factory debt rose slower than its spending budget implied.
The question now is whether high milk costs are a temporary squeeze that price hikes will cure, or whether heavier marketing and debt-funded factory spending have permanently lowered returns. One view is that dairy inflation always passes through with a short lag; the other is that management has not quantified the price hikes and stopped repeating its 2027 profit goal. First-quarter 2027 gross margin, once all price increases and the expanded Waukesha plant are running, will settle it.
🐂 Bull Case
Kefir Volumes Keep Sales Growing Past Tough Comparisons
Lifeway makes drinkable kefir, a fermented probiotic milk drink, along with farmer cheese and newer lines like Kefir Butter and Muscle Mates protein shakes. Chief executive Julie Smolyansky said the volume-led growth for kefir and farmer cheese is extraordinary as supermarkets dedicate more shelf space to fermented dairy.
Third-quarter net sales reached a record $67.8 million, up 18.6% from a year ago. The company attributed the gain primarily to "higher volumes of the Company’s branded drinkable kefir". That marks 28 straight quarters of sales growth from a year ago, even against a tough comparison where sales rose 24% last year.
What to watch: fourth-quarter net sales and the quarterly filing's product breakdown. They will show whether recent retail placements at Target and Meijer keep sales growing above 15% before price increases take full effect.
Price Increases Will Roll Out Through Early 2027
To offset higher milk and packaging bills, Lifeway is raising prices across its product line. Smolyansky said those planned increases will take effect with distributors and retailers "on a rolling basis through the end of the year and into the first quarter of 2027".
This timing explains why third-quarter margins received no relief from pricing yet. Because customer demand has held up through seven years of growth, passing input costs on to retailers should lift gross margin once the new prices are in place early next year.
What to watch: first-quarter 2027 gross margin and sales volume. Rising margins alongside steady volume growth would prove that shoppers accept the higher shelf prices.
🐻 Bear Case
Higher Milk and Packaging Costs Cut Margin Again
Lifeway previously told investors in its second-quarter filing that high milk costs would begin to ease in the fourth quarter. Today, Smolyansky shifted that timeline, stating that "while we expect the cost pressure to persist in the fourth quarter, our outlook for 2027 has not changed".
- Gross profit margin: 18.0%, down from 19.5% last quarter and 28.7% a year ago
- Cost of goods sold: 82.1% of net sales, up 10.8 percentage points from a year ago
- Operating income: $1.1 million, down 78% from $5.0 million a year ago
- Diluted profit per share: $0.02, down from $0.23 a year ago
High milk, plastic resin, ingredient and freight bills wiped out nearly all of the quarter's record revenue gains. Because cost pressure will last through year-end while price hikes only finish rolling out in early 2027, fourth-quarter profits will stay under pressure.
What to watch: fourth-quarter gross margin. A reading below 18% would show input costs are still outrunning the initial price increases.
Factory Build Slowed and Debt Shifted to Equipment Loans
Lifeway is doubling manufacturing capacity at its Waukesha, Wisconsin plant to "eliminate capacity challenges we have encountered" and improve packaging efficiency. While fans view the build as necessary for volume growth, critics point out that the project and a second-quarter share buyback moved the balance sheet from net cash into debt during a profit slump.
By our math, third-quarter capital spending slowed to $3.3 million from $8.5 million in the second quarter, bringing nine-month spending to $22.8 million. Total debt reached $24.0 million against $7.0 million in cash, as Lifeway took out a $12.0 million note payable to pay down $10.0 million of its credit line.
What to watch: total project spending and completion status in the quarterly filing. By our math, about $8.3 million of the $50.5 million project budget remained at quarter end ahead of the early 2027 target.
Selling Costs Still Outpace Sales Growth
Lifeway is spending heavily on marketing and promotions to build brand awareness and support new retail shelves, which bulls see as fuel for volume growth and bears view as a drag on profit. In the release, the dairy group highlighted that combined selling, general and administrative expenses fell to 16.2% of net sales from 19.6% a year ago.
That drop came entirely from general and administrative overhead, which fell 4.2 percentage points of sales to 6.7%. Selling expenses moved the other way, rising 27.5% from a year ago to $6.4 million, or 9.5% of net sales compared with 8.8% last year.
What to watch: advertising expense in the quarterly filing's footnotes. It will show whether marketing spend is still doubling from a year ago while gross margins sit below 20%.
Missing 2027 Profit Target and Unanswered Questions
For a second straight quarter, the earnings release omitted Lifeway's long-standing 2027 goal of $45 million to $50 million in adjusted EBITDA (operating profit before depreciation, amortization and stock-based pay), and several other standing risks received no update.
- 2027 adjusted EBITDA target: omitted again; by our math, nine-month adjusted EBITDA fell 22% from a year ago to $13.1 million.
- Customer concentration: two retailers accounted for 25% of sales in recent filings; updated figures await the quarterly report.
- Earnings call format: past calls have not included live analyst questions; the release announced a webcast Q&A session that will test whether executives take live questions.
What to watch: the conference call transcript and the quarterly filing. Any explicit confirmation or withdrawal of the $45 million to $50 million target will clarify what management means by improved profitability in 2027.
💲 Other KPIs
Uncollected customer bills rose 28.3% from a year ago and 34.3% from year-end, outpacing the 18.6% increase in third-quarter net sales. The allowance for credit losses and discounts also rose to $2.9 million from $1.7 million at year-end, tying up $5.8 million of operating cash over the first nine months.
Stock on hand grew 22.9% from a year ago to support higher kefir sales volumes and higher unit milk costs. Compared with the second quarter, inventory dipped 2.8% from $14.0 million as the company worked through summer shipments.
The diluted share count fell 1.1% from 15.42 million a year ago. Lifeway spent $4.9 million in the second quarter to buy back shares during former shareholder Danone's stock sale, and it bought back no additional shares in the third quarter.
🔮 Guidance
Unchanged. The company still plans to beat last year's record of $212.5 million. With $197.7 million of sales already booked in the first nine months—93% of last year's total—Lifeway needs just $14.8 million in the fourth quarter to set a record.
Unchanged. Smolyansky reiterated that rolling price increases and new factory productivity will lift gross margin and profit in 2027, even though input cost pressure will continue through the fourth quarter of 2026. The company did not give a numerical margin range or mention its prior 2027 EBITDA target.
Unchanged. The scale-up of the Waukesha plant remains scheduled for completion in early 2027, which management says will remove capacity bottlenecks and improve packaging efficiency.
❓ Key Questions
Is the $45–50 million 2027 EBITDA target still active?
The company repeated this target every quarter until the margin drop in the second quarter, and left it out again today. Investors need to know if it still stands after nine-month adjusted EBITDA fell 22%.
How large are the price increases rolling out through Q1?
Management expects price hikes to restore gross margin in 2027, but has not stated the average percentage increase or how much of the 10.8-point gross margin drop comes from milk versus packaging.
What is the remaining budget for the Waukesha expansion?
Capital spending slowed to $3.3 million in the third quarter. Investors need the updated cumulative spend in the quarterly filing to see if the project will finish within the $50.5 million estimate.
How fast are Farmer Cheese and Kefir Butter selling?
The release credits branded drinkable kefir for third-quarter growth. Without store velocities or revenue figures for Farmer Cheese, Muscle Mates and Kefir Butter, investors cannot tell how much the newer lines contribute.